Noveris Health Sciences Inc. (MYCOF) Research

Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.

Market snapshot

Symbol
MYCOF
Price
$2.00
Day change
0.00%
Market cap
$21.4M
P/E ratio
9.80x
52-week range
0.029-2.04
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Next earnings
in 2 months

Peer companies

  • BioQuest Corp. (BQST)
  • Biotricity, Inc. (BTCY)
  • China Health Industries Holdings, Inc. (CHHE)
  • Gemina Laboratories Ltd. (GLABF)
  • Herbal Dispatch Inc. (LUFFF)
  • Vivesto AB (OASMY)
  • PT Kalbe Farma Tbk. (PTKFY)
  • Quest PharmaTech Inc. (QPTFF)

Open Noveris Health Sciences Inc. (MYCOF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.